The Top 10 World's Leading Life Science Intermediate Companies
| Publication Date | January 2008 |
|---|---|
| Publisher | Venture Planning Grp. |
| Product Type | Report |
| Pages | 560 |
| ISBN Number | |
| Product Code | VEP00119 |
Summary
This study provides concise market analysis of major U.S. and international trends with potentially significant impact on the life science intermediates industry during the next five years, e.g., including industry consolidation, market globalization, and environmental regulations; review of major market segments and of key geographic regions, including North America, Europe, Asia, Latin America and others; the 2006-2011 worldwide forecasts for major market segments and key geographic regions. For each of the Top 10 companies, the report provides Business Organization; Senior Management; Facilities and Employees; Technological Know-How; Product Portfolio Analysis; Marketing Tactics; Financial Analysis; R&D Expenditures and Major Programs; Collaborative Arrangements; and Strategic Direction.
Content
- Section I. Executive Summary
- A 3-5 Page Synopsis of Main Sections.
- Section II. Business Organization
- History of The Life Science Intermediates Business Evolution, Important to The Understanding of The Corporate Culture, Management Mentality and Strategies.
- Recent Acquisitions, Divestitures and Significant Organizational Changes.
- Current Organizational Structure.
- Section III. Senior Management
- Background of Key Executives.
- Section IV. Facilities and Employees
- Major Administrative, Manufacturing and R&D Facilities in The U S. and Abroad.
- New Plants under Construction.
- U S. and International Work Force Size and Distribution.
- Section V Technological Know-How
- Internally Developed and Acquired Technologies, and Related Capabilities.
- Proprietary Technologies and Patent Litigations.
- Section VI. Product Portfolio
- Extensive Review of Major Product Lines.
- Section VII. Marketing Tactics
- Major Promotional Strategies.
- Distribution Approaches.
- Product Service and Support.
- Section VIII. Financial Analysis
- Sales and Operating Profit by Division, Product Line, Geographic Region and Country.
- Five-Year Sales and Profit Performance.
- Section IX. R&D Expenditures and Major Programs
- Estimated R&D Budget.
- Research Facilities and Staff.
- New Technologies, Products and Applications in Development.
- Section X. Collaborative Arrangements
- Major Joint Venture, Distribution, OEM and Licensing Partners, Both Industrial and Academic.
- Terms of Collaborative Agreements and Specific Products Involved.
- Section XI. Strategic Direction
- Specific Business, New Product Development and Marketing Strategies.
- Strengths and Weaknesses.
- Anticipated Acquisitions, Joint Ventures and Divestitures.
- List of Tables
- Table Bf-1: Basf Sales and Operating Profit Growth
- Table Bf-2: Basf Sales by Business Segment
- Table Bf-3: Basf Sales Growth by Business Segment
- Table Bf-4: Basf Operating Profit by Business Segment
- Table Bf-5: Basf Plastics Sales by Division
- Table Bf-6: Basf Performance Products Sales by Division
- Table Bf-7: Basf Chemical Sales by Division
- Table Bf-8: Basf Agricultural Products and Nutrition Sales by Division
- Table Bf-9: Basf Sales by Geographic Region
- Table Br-1: Bayer Sales by Business Segment
- Table Br-2: Bayer Sales Growth by Business Segment
- Table Br-3: Bayer Sales by Geographic Region
- Table Br-4: Bayer Sales Growth by Geographic Region
- Table Br-5: Lanxess Sales and Operating Profit Growth
- Table Br-6: Lanxess Sales by Product Line
- Table Br-7: Lanxess Sales Growth by Product Line
- Table Cx-1: Cambrex Sales and Operating Profit Growth
- Table Cx-2: Cambrex Sales by Business Segment
- Table Cx-3: Cambrex Sales Growth by Business Segment
- Table Cx-4: Cambrex Operating Profit and Margins by Business Segment
- Table Cx-5: Cambrex Operating Profit Growth by Business Segment
- Table Cx-6: Cambrex Sales by Product Group
- Table Cx-7: Cambrex Sales Growth by Product Group
- Table Cx-8: Cambrex Sales by Geographic Region
- Table Cx-9: Cambrex Sales Growth by Geographic Region
- Table Cl-1: Clariant Sales by Division
- Table Cl-2: Clariant Sales Growth by Division
- Table Cl-3: Clariant Profit by Division
- Table Cl-4: Clariant Profit Growth by Division
- Table Cl-5: Clariant Sales by Geographic Region
- Table De-1: Degussa Sales and Operating Profit Growth
- Table De-2: Degussa Sales by Division
- Table De-3: Degussa Sales Growth by Division
- Table De-4: Degussa Fine and Industrial Chemical Sales by Business Unit
- Table De-5: Degussa Coatings and Advanced Fillers Sales by Business Unit
- Table De-6: Degussa Performance Materials Sales by Business Unit
- Table De-7: Degussa Construction Chemicals Sales by Business Unit
- Table De-8: Degussa Specialty Polymers Sales by Business Unit
- Table De-9: Degussa Sales by Geographic Region and Country
- Table Do-1: Dow Chemical Sales and Operating Profit Growth
- Table Do-2: Dow Chemical Sales by Operating Segment
- Table Do-3: Dow Chemical Sales Growth by Operating Segment
- Table Do-4: Dow Chemical Sales by Geographic Region
- Table Do-5: Dow Chemical Sales Growth by Geographic Region
- Table Dm-1: Dsm Sales and Operating Profit Growth
- Table Dm-2: Dsm Sales by Division
- Table Dm-3: Dsm Sales Growth by Division
- Table Dm-4: Dsm Operating Profit by Division
- Table Dm-5: Dsm Operating Profit Growth by Division
- Table Dm-6: Dsm Life Science Products Sales by Business Group
- Table Dm-7: Dsm Life Science Products Sales Growth by Business Group
- Table Dm-8: Dsm Performance Materials Sales by Business Group
- Table Dm-9: Dsm Performance Materials Sales Growth by Business Group
- Table Dm-10: Dsm Industrial Chemicals Sales by Business Group
- Table Dm-11: Dsm Industrial Chemicals Sales Growth by Business Group
- Table Ds-1: Groupe Novasep Proforma Sales by Customer Group
- Table Lo-1: Lonza Sales and Operating Profit Growth
- Table Lo-2: Lonza Sales by Division
- Table Lo-3: Lonza Sales Growth by Division
- Table Lo-4: Lonza Operating Profit by Division
- Table Lo-5: Lonza Operating Profit Growth by Division
- Table Lo-6: Lonza Exclusive Synthesis & Biopharmaceutical Division Sales by Molecular Size
- Table Lo-7: Lonza Exclusive Synthesis & Biopharmaceutical Division Sales Growth by Molecular Size
- Table Lo-8: Lonza Sales by Geographic Region
- Table Lo-9: Lonza Sales Growth by Geographic Region
- Table Lo-10: Lonza Exclusive Synthesis & Pharmaceuticals Sales by Geographic Region
- Table Lo-11: Lonza Exclusive Synthesis & Pharmaceuticals Sales Growth by Geographic Region
- Table Lo-12: Lonza Organic Fine & Performance Chemicals Sales by Geographic Region
- Table Lo-13: Lonza Organic Fine & Performance Chemicals Sales Growth by Geographic Region
- Table Lo-14: Lonza Polymer Intermediates Sales by Geographic Region
- Table Lo-15: Lonza Polymer Intermediates Sales Growth by Geographic Region
- Table Rh-1: Rhodia Sales and Operating Profit Growth
- Table Rh-2: Rhodia Sales by Enterprise
- Table Rh-3: Rhodia Sales Growth by Enterprise
- Table Rh-4: Rhodia Operating Profit and Margins by Enterprise
- Table Rh-5: Rhodia Operating Profit Growth by Enterprise
- Table Rh-6: Rhodia Sales by Geographic Region and Country
- Table Rh-7: Rhodia Sales Growth by Geographic Region and Country
About this Product
Delivery Details
PDF:Delivered by email usually within 12 to 24 UK business hours.
PRINT/CD-ROM:Despatched within 1 to 2 working days.
Related Products
Recently Viewed Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















